BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.500
-0.100 (-6.25%)
At close: Jan 30, 2026
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 39.16 million as of January 30, 2026. Its market cap has decreased by -59.44% in one year.
Market Cap
39.16M
Enterprise Value
-6.64M
Revenue
42.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 39.16M, an increase of 23,922.21%. That is a compound annual growth rate of 33.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 39.16M | -6.25% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 434.47M |
| Geffen Residence & Renewal | 261.69M |
| Matricelf | 143.84M |
| Clal Biotechnology Industries | 48.47M |
| BioLight Life Sciences | 34.65M |
| Evogene | 27.76M |
| XTL Biopharmaceuticals | 25.55M |
| Purple Biotech | 20.44M |